MediciNova Director Nagao Hideki Granted 44,500 Stock Options at $1.36 Exercise Price

This Form 4 filing reports that Nagao Hideki, a director of MediciNova Inc., was granted 44,500 stock options on June 23, 2026. The options have an exercise price of $1.36 per share and expire on June 22, 2036. The options vest in four equal installments on September 30, 2026, December 31, 2026, March 31, 2027, and June 30, 2027, contingent upon continued service with the company. This represents a standard equity compensation award to a non-employee director, providing incentive alignment with shareholders. The transaction was reported by the company's attorney-in-fact, Yuichi Iwaki, on June 25, 2026. Stock options are a common form of director compensation that link director compensation to company performance through stock price appreciation.